References
- Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68–91.
- Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ, Hill DJ. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994;79:1871–6.
- Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513–20.
- Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986;63:651–5.
- Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 1998;21 Suppl 1:S5–S19.
- Sheppard MS, Minuk GY, Bhaumick B, Bala RM. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II. Clin Invest Med 1987;10:49–53.
- Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995;21:680–8.
- Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulinlike growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995;80:1148–57.
- Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997;27: 796–802.
- Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997;13:185–90.
- Moller S, Becker U, Juul A, Skakkebaek NE, Christensen E. Prognostic value of insulin-like growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD group. Hepatology 1996;23:1073–8.
- Shaarawy M, Fikry MA, Massoud BA, Lotfy S. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. J Clin Endocrinol Metab 1998;83:3316–9.
- Caregaro L, Alberino F, Angeli P, Gatta A. Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: a marker of hepatocellular dysfunction? J Hepatol 1998;29:342.
- Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, et al. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 1998;15:2165–73.
- Del Monte P, Bernasconi D, De Conca V, Randazzo M, Meozzi M, Badaracco B, et al. Endocrine evaluation in patients treated with interferon-alpha for chronic hepatitis C. Horm Res 1995;44:105–9.
- Chin E, Zhou J, Dai J, Baxter RC, Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994;134:2498–2504.
- Villafuerte BC, Koop BL, Pao CI, Gu L, Birdsong GG, Phillips LS. Coculture of primary rat hepatocytes and non-parenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology 1994;134:2044–50.
- Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591–614.